---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
redirect_from:
  - /resume
---

2023
* Nasu I, Kondo M, **Uozumi R**, Takada S, Nawata S, Iihara H, Okumura Y, Takemoto M, Mino K, Sasaki T, Hirose C, Aomori T, Shimano R, Maeno K, Oizumi S, Kusumoto S, Ohno Y, Ikemura S, Takai D, Hara A, Kawazoe H, Nakamura T. Prognostic model of baseline medications plus neutrophil-to-lymphocyte ratio in patients with advanced non-small-cell lung cancer receiving first-line immune-platinum regimen: A multicenter retrospective study. Journal of Cancer. 14(5), 676-688, 2023. DOI: 10.7150/jca.80517.

* Onishi A, Torii M, Hidaka Y, **Uozumi R**, Oshima Y, Tanaka H, Onizawa H, Fujii T, Murata K, Murakami K, Tanaka M, Matsuda S, Morinobu A, Arai H, Hashimoto M. Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial. BMC Musculoskeletal Disorders. 24(1), 280, 2023. DOI: 10.1186/s12891-023-06185-4.

* Yao S, Yagi S, Hirata M, Miyachi Y, Ogawa E, **Uozumi R**, Sugimoto T, Asahara T, Uemoto S, Hatano E. Chronological changes in the gut microbiota and intestinal environment in recipients and donors of living donor liver transplantation. Journal of Hepato-Biliary-Pancreatic Sciences. 30(4), 439-452, 2023. DOI: 10.1002/jhbp.1241.

2022
* **Uozumi R**, Yada S, Maruo K, Kawaguchi A. Confidence intervals for the difference between two binomial proportions derived from logistic regression. Communications in Statistics - Simulation and Computation. 51(6), 3223-3236, 2022. DOI: 10.1080/03610918.2019.1710195. 

* Murata K, **Uozumi R**, Hashimoto M, Ebina K, Akashi K, Onishi A, Nagai K, Yoshikawa A, Katayama M, Son Y, Amuro H, Hara R, Yamamoto W, Watanabe R, Murakami K, Tanaka M, Ito H, Morinobu A, Matsuda S. The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: the ANSWER cohort study. Modern Rheumatology. 32(4), 834-838, 2022. DOI: 10.1093/mr/roab043. 

* Akiyama N, **Uozumi R**, Akiyama T, Koeda K, Shiroiwa T, Ogasawara K. Choking injuries: Associated factors and error producing conditions among acute hospital patients in Japan.  PLoS One. 17(4), e0267430, 2022. DOI: 10.1371/journal.pone.0267430.

* Yamazaki T, **Uozumi R**, Kawazoe H, Kitazume Y, Iihara H, Fujii H, Takahashi M, Arai T, Murachi Y, Sato Y, Mikami T, Hashiguchi K, Yoshizawa T, Takahashi K, Fujita Y, Hosokawa Y, Morozumi I, Tsuchiya M, Yokoyama A, Hashimoto H, Furukawa T. Association between the Co-administration of Histamine H2 Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis. Journal of Cancer. 13(10), 3073-3083, 2022. DOI: 10.7150/jca.73385. 

* Kitazume Y, Kawazoe H, **Uozumi R**, Yoshizawa T, Iihara H, Fujii H, Takahashi M, Arai T, Murachi Y, Sato Y, Mikami T, Hashiguchi K, Yamazaki T, Takahashi K, Fujita Y, Hosokawa Y, Morozumi I, Tsuchiya M, Yokoyama A, Hashimoto H, Yamaguchi M. Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study. Scientific Reports. 12:6561, 2022. DOI: 10.1038/s41598-022-10008-2. 

* Morimoto Y, Ishiguro T, **Uozumi R**, Takano K, Kobayashi Y, Shimizu Y, Takayanagi N. Significance of hypophosphatemia in patients with pneumonia. Internal Medicine. 61(7), 979-988, 2022. DOI: 10.2169/internalmedicine.6949-20. 

* Akiyama N, Koeda K, **Uozumi R**, Takahashi F, Ogasawara K. Implementing an Intervention to Improve Physicians’ Incident Reporting in the Hospital Setting: A Pilot Study. Patient Safety. 4(1), 18-25, 2022. DOI: 10.33940/culture/2022.3.2.

* Yamamoto S, Iihara H, **Uozumi R**, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige K, Inui N. Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis. BMC Cancer. 22(1), 310, 2022. DOI: 10.1186/s12885-022-09392-9. 

* Tanigami Y, Kawai Y, Kaba S, **Uozumi R**, Ohnishi H, Kita T, Omori K, Kishimoto Y. Establishment of a Radiation-induced Vocal Fold Fibrosis Mouse Model. Biochemical and Biophysical Research Communications. 601, 31-37, 2022. DOI: 10.1016/j.bbrc.2022.02.065. 

* Handa T, Tanizawa K, Oguma T, **Uozumi R**, Watanabe K, Tanabe N, Niwamoto T, Shima H, Mori R, Nobashi TW, Sakamoto R, Kubo T, Kurosaki A, Kishi K, Nakamoto Y, Hirai T. Novel artificial intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis. Annals of the American Thoracic Society. 19(3), 399-406, 2022. DOI: 10.1513/AnnalsATS.202101-044OC.

* Takada M, Yoshimura M, Kotake T, Kawaguchi K, **Uozumi R**, Kataoka M, Kato H, Yoshibayashi H, Suwa H, Tsuji W, Yamashiro H, Suzuki E, Torii M, Yamada Y, Kataoka T, Ishiguro H, Morita S, Toi M. Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer. Scientific Reports. 12(1), 22397, 2022. DOI: 10.1038/s41598-022-27048-3. 

* Yao S, Yagi S, Ogawa E, Hirata M, Miyachi Y, Iwamura S, **Uozumi R**, Sugimoto T, Asahara T, Uemoto S, Hatano E. Dysbiosis and depletion of fecal organic acids correlate with the severity of rejection after rat liver transplantation. Transplant International. 35, 10728, 2022. DOI: 10.3389/ti.2022.10728.
	
* Watanabe T, Yoshida T, Akizuki S, Yamanaka S, Nakao K, Fukuhara S, Asai K, **Uozumi R**, Bessho K. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study. Journal of Bone and Mineral Metabolism. 40(4), 657-662, 2022. DOI: 10.1007/s00774-022-01329-3. 

* Imamura K, Izumi Y, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Egawa N, Ayaki T, Oki R, Fujita K, **Uozumi R**, Morinaga A, Hirohashi T, Fujii Y, Yamamoto T, Tatebe H, Tokuda T, Takahashi N, Morita S, Takahashi R, Inoue H. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial. eClinicalMedicine. 53, 101707, 2022. DOI: 10.1016/j.eclinm.2022.101707. 
	
* Mori Y, Kikuchi O, Horimatsu T, Hara H, Hironaka S, Kojima T, Kato K, Tsushima T, Ishihara R, Mukai K, **Uozumi R**, Tada H, Kasai H, Kawaguchi A, Muto M. Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, or taxanes: the ECTAS study. Esophagus. 19(3), 444-451, 2022. DOI: 10.1007/s10388-021-00905-2.

* Goto T, Kimura H, Yoshino T, Sawada A, Akamatsu S, Kobayashi T, Yamasaki T, Tazawa S, Fujimoto M, Hidaka Y, **Uozumi R**, Morita S, Ogawa O, Inoue T. Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study. International Journal of Translational Medicine. 2(4), 618-632, 2022. DOI: 10.3390/ijtm2040047. 


2021
*	Hirabayashi S, **Uozumi R**, Kondo T, Arai Y, Kawata T, Uchida N, Marumo A, Ikegame K, Fukuda T, Eto T, Tanaka M, Wake A, Kanda J, Kimura T, Tabuchi K, Ichinohe T, Atsuta Y, Yanada M, Yano S. Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT. Cancer Medicine. 10(13), 4250-4268, 2021. DOI: 10.1002/cam4.3920. 

* Tominari M, **Uozumi R**, Becker C, Kinoshita A. Reminiscence therapy using virtual reality technology affects cognitive function and subjective well-being in older adults with dementia. Cogent Psychology. 8(1), 1968991, 2021. DOI: 10.1080/23311908.2021.1968991. 

*	Akiyama Y, Ishiguro T, **Uozumi R**, Nishida T, Kobayashi Y, Takayanagi N. Specific pathogens as predictors of poor long-term prognosis after hospital discharge for community-acquired pneumonia. Respiratory Medicine. 176, 106279, 2021. DOI: 10.1016/j.rmed.2020.106279.  

* Hosoda C, Ishiguro T, **Uozumi R**, Ueda M, Takata N, Takayanagi N. Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis. BMJ Open Respiratory Research. 8(1), e000805, 2021. DOI: 10.1136/bmjresp-2020-000805.

* Yamamoto S, Iihara H, **Uozumi R**, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige K, Inui N. Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials. BMC Cancer. 21(1), 832, 2021. DOI: 10.1186/s12885-021-08572-3. 

* Uda M, Hashimoto M, **Uozumi R**, Torii M, Fujii T, Tanaka M, Furu M, Ito H, Terao C, Yamamoto W, Sugihara G, Nakagami Y, Mimori T, Nin K. Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study. Advances in Rheumatology. 61(1), 65, 2021. DOI: 10.1186/s42358-021-00223-2.

*	Arami T, Kawazoe H, **Uozumi R**, Hashimoto H, Egami S, Sakiyama N, Ohe Y, Nakada H, Aomori T, Ikemura S, Yasuda H, Kawada I, Fukunaga K, Soejima K, Yamaguchi M, Nakamura T. Effect of renin-angiotensin system inhibitors on pemetrexed plus platinum-induced hematological toxicities: a multicenter retrospective study using three propensity score analyses. Pharmazie. 76(6), 266-271, 2021. DOI: 10.1691/ph.2021.1409.

*	Shimanuki Y, Hashimoto H, Kawazoe H, **Uozumi R**, Udagawa R, Watabe D, Nakamura T, Yamaguchi M, Terakado H. Preventive effects of self-administered cryotherapy on paclitaxel-induced peripheral neuropathy in patients with early-stage breast cancer: a propensity score analysis. Pharmazie. 76(6), 261-265, 2021. DOI: 10.1691/ph.2021.1398.

*	Egami S, Kawazoe H, Hashimoto H, **Uozumi R**, Arami T, Sakiyama N, Ohe Y, Nakada H, Aomori T, Ikemura S, Fukunaga K, Yamaguchi M, Nakamura T. Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective study. Journal of Cancer. 12(7), 2105-2112, 2021. DOI: 10.7150/jca.53242.

*	Egami S, Kawazoe H, Hashimoto H, **Uozumi R**, Arami T, Sakiyama N, Ohe Y, Nakada H, Aomori T, Ikemura S, Fukunaga K, Yamaguchi M, Nakamura T. Absolute Lymphocyte Count Predicts Immune-related Adverse Events in Patients with Non-small-cell Lung Cancer Treated with Nivolumab Monotherapy: A Multicenter Retrospective Study. Frontiers in Oncology. 11, 618570, 2021. DOI: 10.3389/fonc.2021.618570. 

*	Kusakabe J, Yagi S, Sasaki K, **Uozumi R**, Abe H, Okamura Y, Taura K, Kaido T, Uemoto S. Is 0.6% reasonable as the minimum requirement of the graft-to-recipient weight ratio regardless of lobe selection in adult living-donor liver transplantation? Transplantation. 105(9), 2007-2017, 2021. DOI: 10.1097/TP.0000000000003472. 

*	Watanabe T, Asai K, Fukuhara S, **Uozumi R**, Bessho K. Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage. PLoS One. 16(1), e0244859129, 2021. DOI: 10.1371/journal.pone.0244859.

*	Murashima-Suginami A, Kiso H, Tokita Y, Mihara E, Nambu Y, **Uozumi R**, Tabata Y, Bessho K, Takagi J, Sugai M, Takahashi K. Anti-USAG-1 therapy for tooth regeneration through enhanced BMP signaling. Science Advances. 7(7), eabf1798, 2021. DOI: 10.1126/sciadv.abf1798.

*	Funada S, Watanabe N, Goto T, Negoro H, Akamatsu S, **Uozumi R**, Kishimoto S, Ichioka K, Segawa T, Furukawa TA, Ogawa O. Clinical Feasibility and Acceptability of Adding Cognitive Behavioral Therapy to Pharmacotherapy for Drug-resistant Overactive Bladder in Women: A Single Arm Pilot Trial. Lower Urinary Tract Symptoms (LUTS). 13(1), 69-78, 2021. DOI: 10.1111/luts.12333. 

* Mishima S, Takahashi K, Kiso H, Murashima-Suginami A, Tokita Y, Jo J, **Uozumi R**, Nambu Y, Huang B, Harada H, Komori T, Sugai M, Tabata Y, Bessho K. Local application of Usag-1 siRNA can promote tooth regeneration in Runx2-deficient mice. Scientific Reports. 11, 13674, 2021. DOI: 10.1038/s41598-021-93256-y. 

* Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, **Uozumi R**, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Maki T, Yasuda K, Taruno Y, Takahashi R, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Kamae K, Osawa Y, Kutoku Y, Sunada Y, Shiota S, Watanabe T, Uchikawa O, Tomimoto H, Inoue H. Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: Randomised Placebo-Controlled Double-Blind Comparative Trial and Open-Label Extension Trial to Investigate the Safety and Efficacy of Bromocriptine in Alzheimer’s Disease with Presenilin 1 (PSEN1) Mutations. BMJ Open. 11(6), e051343, 2021. DOI: 10.1136/bmjopen-2019-033131.

*	Iima M, Kataoka M, Honda M, Ohashi A, Ohno-Kishimoto A, Ota R, **Uozumi R**, Urushibata Y, Feiweier T, Toi M, Nakamoto Y. The Rate of Apparent Diffusion Coefficient Change With Diffusion Time on Breast Diffusion-Weighted Imaging Depends on Breast Tumor Types and Molecular Prognostic Biomarker Expression. Investigative Radiology. 56(8), 501-508, 2021. DOI: 10.1097/RLI.0000000000000766. 

* Kondo K, Mizuta M, Kawai Y, Kojima T, Abe C, Tanaka R, Shiromoto O, **Uozumi R**, Kishimoto Y, Tateya I, Omori K, Haji T. Development and validation of the Japanese version of the Consensus Auditory-Perceptual Evaluation of Voice. Journal of Speech, Language, and Hearing Research. 64(12), 4754-4761, 2021. DOI: 10.1044/2021_JSLHR-21-00269. 

*	Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, **Uozumi R**, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K. Safety and efficacy of the cyclin dependent kinase 9 (CDK9) inhibitor FIT039 for verruca vulgaris: a placebo-controlled, phase I/II randomized controlled trial. JID Innovations. 1(3), 100026, 2021. DOI: 10.1016/j.xjidi.2021.100026.

*	Oiwa T, Ishibashi M, Endo Y, Ohba M, Okuno T, Yokomizo T, Yoshida K, Niizeki H, Ghazawi FM, **Uozumi R**, Nomura T, Kabashima K. Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations. The Journal of Dermatology. 48(9), 1442-1446, 2021. DOI: 10.1111/1346-8138.16012. 

* Niwamoto T, Handa T, Murase Y, Nakatsuka Y, Tanizawa K, Taguchi Y, Tomioka H, Tomii K, Kita H, Fukui M, Nagasaka Y, Emura M, Kawamura T, Saito T, Arita M, Uno K, Yoshizawa A, **Uozumi R**, Yamaguchi I, Matsuda F, Chin K, Hirai T. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study. Respiratory Research. 22(1), 181, 2021. DOI: 10.1186/s12931-021-01779-9.

* Takase Y, Iwasaki T, Doi H, Tsuji H, Hashimoto M, Ueno K, Inaba R, Kozuki T, Taniguchi M, Tabuchi Y, Watanabe R, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Itaya T, Yamamoto W, **Uozumi R**, Tanaka M, Ohmura K, Morinobu A. Correlation between irreversible organ damage and the Quality of Life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort survey. Lupus. 30(10), 1577-1585, 2021. DOI: 10.1177/09612033211025614.

*	Masuda N, Bando H, Yamanaka T, Kadoya T, Takahashi M, Nagai SE, Ohtani S, Aruga T, Suzuki E, Kikawa Y, Yasojima H, Kasai H, Ishiguro H, Kawabata H, Morita S, Haga H, Kataoka TR, **Uozumi R**, Ohno S, Toi M. Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial. Breast Cancer Research and Treatment. 188(1), 117-131, 2021. DOI: 10.1007/s10549-021-06184-w.  


2020
* **Uozumi R**, Hamada C. Utility-based interim decision rule planning in adaptive population selection designs with survival endpoints. Statistics in Biopharmaceutical Research. 12(3), 360-368, 2020. DOI: 10.1080/19466315.2019.1689844.

*	Ishiguro T, **Uozumi R**, Yoshioka H, Nishida T, Takayanagi N. Comparison between Patients with Chest Infection due to Klebsiella spp. and Streptococcus pneumoniae. Internal Medicine. 59(5), 611-618, 2020. DOI: 10.2169/internalmedicine.3531-19. 

*	Fujii K, Sakanaka K, **Uozumi R**, Ishida Y, Inoo H, Tsunoda S, Miyamoto S, Muto M, Mizowaki T. Association of Chemoradiotherapy with Thoracic Vertebral Fractures in Patients with Esophageal Cancer. JAMA Network Open. 3(9):e2013952, 2020. DOI: 10.1001/jamanetworkopen.2020.13952. 

*	Kamo N, Kaido T, **Uozumi R**, Ito T, Yagi S, Hata K, Masui T, Taura K, Uemoto S. Effect of administration of β-hydroxy-β-methyl butyrate-enriched formula after liver transplantation: A pilot randomized controlled trial. Nutrition. 79-80, 110871, 2020. DOI: 10.1016/j.nut.2020.110871. 

*	Yao S, Kaido T, **Uozumi R**, Hirata M, Iwamura S, Miyachi Y, Macshut M, Sharshar M, Yagi S, Uemoto S. Diagnostic potential of presepsin in bacterial infection following hepato-biliary-pancreatic surgery: A prospective observational study. Journal of Hepato-Biliary-Pancreatic Sciences. 27(10), 756-766, 2020. DOI: 10.1002/jhbp.802. 

*	Kawazoe H, Mori N, Ido S, **Uozumi R**, Tsuneoka K, Takeuchi A, Matsuo M, Yamauchi M, Nakai M, Sumikawa S, Nakamura T, Yakushijin Y. Liquid formulation of gemcitabine increases venous pain in patients with cancer: A retrospective study. Clinical Therapeutics. 42(4), 712-719, 2020. DOI: 10.1016/j.clinthera.2020.02.010. 

*	Funada S, Watanabe N, Goto T, Negoro H, Akamatsu S, Ueno K, **Uozumi R**, Ichioka K, Segawa T, Akechi T, Furukawa TA, Ogawa O. Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial. BMC Urology. 20(1):129, 2020. DOI: 10.1186/s12894-020-00697-0. 

*	Miyachi Y, Kaido T, Hirata M, Iwamura S, Yao S, Shirai H, Kamo N, **Uozumi R**, Yagi S, Uemoto S. The combination of male donor’s high muscle mass and quality is an independent protective factor for graft loss after living donor liver transplantation. American Journal of Transplantation. 20(12), 3401-3412, 2020. DOI: 10.1111/ajt.15884. 

*	Miyachi Y, Yagi S, Hirata M, Iwamura S, Yao S, Shirai H, Okumura S, Iida T, Ito T, **Uozumi R**, Kaido T, Uemoto S. Etiology of Liver Steatosis Influences the Severity of Ischemia/Reperfusion Injury and Survival After Liver Transplantation in Rats. Liver Transplantation. 26(11), 1504-1515, 2020. DOI: 10.1002/lt.25814. 

*	Hattori Y, Kono Y, Itoh S, Inoue T, Urata Y, Kawa Y, Tohnai R, Kumagai T, Nishino K, **Uozumi R**, Morita S, Negoro S, Imamura F, Satouchi M. A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer. BMC Cancer. 20(1):115, 2020. DOI: 10.1186/s12885-020-6588-y. 

*	Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, **Uozumi R**, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T. Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy with High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis. Arthritis & Rheumatology. 72(3), 488-498, 2020. DOI: 10.1002/art.41105.

2019
* **Uozumi R**, Yada S, Kawaguchi A. Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints. BMC Medical Research Methodology. 19(1):159, 2019. DOI: 10.1186/s12874-019-0800-2. 

*	Akamatsu S, Kubota M, **Uozumi R**, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, Hoshi S, Ishida M, Mizuno K, Ogura K, Goto T, Terada N, Kobayashi T, Yamasaki T, Inoue T, Tsuchiya N, Ohyama C, Arai Y, Habuchi T, Morita S, Ogawa O. Development and validation of a novel prognostic model for predicting overall survival in treatment-naïve castration-sensitive metastatic prostate cancer. European Urology Oncology. 2(3), 320-328, 2019. DOI: 10.1016/j.euo.2018.10.011. 

*	Ishiguro T, Kobayashi Y, **Uozumi R**, Takata N, Takaku Y, Kagiyama N, Kanauchi T, Shimizu Y, Takayanagi N. Viral pneumonia requiring differentiation from acute and progressive diffuse interstitial lung diseases. Internal Medicine. 58(24), 3509-3519, 2019. DOI: 10.2169/internalmedicine.2696-19. 

*	Kamo N, Kaido T, **Uozumi R**, Yagi S, Okajima H, Uemoto S. Preoperative Ascites and/or Pleural Effusion Was a Predictor of Massive Albumin Use After Liver Transplantation. Surgery, Gastroenterology and Oncology. 24(1), 22-30, 2019. DOI: 10.21614/sgo-24-1-22. 

*	Yao S, Kaido T, Yagi S, **Uozumi R**, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S. Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated. American Journal of Transplantation. 19(10), 2783-2794, 2019. DOI: 10.1111/ajt.15337.

*	Sumi E, Nomura T, Asada R, **Uozumi R**, Tada H, Amino Y, Sawada T, Yonezawa A, Hagiwara M, Kabashima K. The safety and pharmacokinetics of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, administered by single adhesive skin patch application on normal skin and cutaneous warts. Clinical Drug Investigation. 39(1), 55-61, 2019. DOI: 10.1007/s40261-018-0712-7.  

*	Imamura K, Izumi Y, Banno H, **Uozumi R**, Morita S, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase 1 dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. BMJ Open. 9(12):e033131, 2019. DOI: 10.1136/bmjopen-2019-033131. 

*	Yao S, Yagi S, Nagao M, **Uozumi R**, Iida T, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Okumura S, Hamaguchi Y, Masano Y, Kaido T, Okajima H, Uemoto S. Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation. European Journal of Clinical Microbiology & Infectious Diseases. 27(10), 1973-1982, 2018. DOI: 10.1007/s10096-018-3333-4. 

*	Matsuo T, Hashimoto M, Ito I, Kubo T, **Uozumi R**, Furu M, Ito H, Fujii T, Tanaka M, Terao C, Kono H, Mori M, Hamaguchi M, Yamamoto W, Ohmura K, Morita S, Mimori T. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study. The Scandinavian Journal of Rheumatology. 48(2), 87-94, 2019. DOI: 10.1080/03009742.2018.1477989. 

*	Suzuki E, Sugimoto M, Kawaguchi K, Pu F, **Uozumi R**, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Breast Cancer. 26(3), 282-289, 2019. DOI: 10.1007/s12282-018-0920-2.

*	Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, **Uozumi R**, Tada H, Nakagawa T, Hagiwara M, Kabashima K. The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial. Trials. 20:489, 2019. DOI: 10.1186/s13063-019-3570-6. 

*	Torii M, Hashimoto M, Hanai A, Fujii T, Furu M, Ito H, **Uozumi R**, Hamaguchi M, Terao C, Yamamoto W, Uda M, Nin K, Morita S, Arai H, Mimori T. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Modern Rheumatology. 29(4), 589-595, 2019. DOI: 10.1080/14397595.2018.1510565.  

*	Kiso H, Takahashi K, Mishima S, Murashima-Suginami A, Kakeno A, Yamazaki T, Asai K, Tokita Y, **Uozumi R**, Sugai M, Harada H, Huang B, MacDougall M, Bessho K. Third dentition is the main cause of premolar supernumerary tooth formation. Journal of Dental Research. 98(9), 968-974, 2019. DOI: 10.1177/0022034519858282. 

*	Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, **Uozumi R**, Yagi S, Uemoto S. Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies. Clinical Nutrition. 38(6), 2770-2777, 2019. DOI: 10.1016/j.clnu.2018.12.004.

*	Nakatsuka Y, Handa T, Nakashima R, Tanizawa K, Kubo T, Murase Y, Sokai A, Ikezoe K, Hosono Y, Watanabe K, Tokuda S, Uno K, Yoshizawa A, Tsuruyama T, **Uozumi R**, Nagai S, Hatta K, Taguchi Y, Mishima M, Chin K, Mimori T, Hirai T. Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease. Rheumatology. 58(8), 1465-1473, 2019. DOI: 10.1093/rheumatology/kez065. 

2018
*	Kawazoe H, **Uozumi R**, Murakami A, Yamashita M, Kobayashi-Taguchi K, Kusakabe E, Yamasawa H, Yakushijin Y, Nakamura T, Kamei Y. Olanzapine plus aprepitant, palonosetron, and dexamethasone for nausea and vomiting in patients with breast cancer receiving anthracycline: A retrospective study. Scientific Reports. 8:16232, 2018. DOI: 10.1038/s41598-018-34618-x. 

*	Yao S, Kaido T, **Uozumi R**, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S. Is portal venous pressure modulation still indicated for all recipients in living-donor liver transplantation? Liver Transplantation. 24(11), 1578-1588, 2018. DOI: 10.1002/lt.25180. 

*	Yao S, Yagi S, **Uozumi R**, Iida T, Nagao M, Okamura Y, Anazawa T, Okajima H, Kaido T, Uemoto S. A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation. Transplantation. 102(4), 623-631, 2018. DOI: 10.1097/TP.0000000000002047. 

*	Kishimoto Y, Sogami T, **Uozumi R**, Funakoshi M, Miyamoto SI, Kitamura M, Suzuki C, Muto M, Tateya I, Omori K. Complications after endoscopic laryngopharyngeal surgery. The Laryngoscope. 128(7), 1546-1550, 2018. DOI: 10.1002/lary.26953. 

*	Kamo N, Kaido T, Hamaguchi Y, **Uozumi R**, Okumura S, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S. Impact of enteral nutrition with an immunomodulating diet enriched with hydrolyzed whey peptide on infection after liver transplantation. World Journal of Surgery. 42(11), 3715-3725, 2018. DOI: 10.1007/s00268-018-4680-0. 

*	Uchida M, Kawazoe H, Takatori S, Namba H, **Uozumi R**, Tanaka A, Kawasaki H, Araki H. Preventive effects of renin-angiotensin system inhibitors on oxaliplatin-induced peripheral neuropathy: A retrospective observational study. Clinical Therapeutics. 40(7), 1214-1222, 2018. DOI: 10.1016/j.clinthera.2018.05.011. 

*	Dahy K, Takahashi K, Saito K, Kiso H, Rezk I, Oga T, **Uozumi R**, Chin K, Bessho K. Gender differences in morphological and functional outcomes after mandibular setback surgery. Journal of Cranio-Maxillofacial Surgery. 46(6), 887-892, 2018. DOI: 10.1016/j.jcms.2018.04.006. 

*	Tsuji T, Nakamura R, Katsuno T, Kishimoto Y, Suehiro A, Yamashita M, **Uozumi R**, Nakamura T, Tateya I, Omori K. Long-term preservation of planar cell polarity in reversed tracheal epithelium. Respiratory Research. 19(1), 22, 2018. DOI: 10.1186/s12931-018-0726-y. 

*	Nomura Y, Takei N, Ishii T, Takada K, Amitani Y, Koganezawa H, Fukuhara S, Asai K, **Uozumi R**, Bessho K. Factors that affect oral care outcomes for institutionalized elderly. International Journal of Dentistry. 2018, 2478408, 2018. DOI: 10.1155/2018/2478408. 

*	Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, **Uozumi R**, Kanao S, Tanaka Y, Hamazaki Y, Minato N, Toi M. Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer. The Breast. 38, 114-119, 2018. DOI: 10.1016/j.breast.2017.12.017.  

*	Yoshida T, Hashimoto M, Kawahara R, Yamamoto H, Tanaka M, Ito H, Masuda I, Hosoda K, Yamamoto W, **Uozumi R**, Morita S, Fujii Y, Mimori T, Nin K. Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology International. 38(9), 1679-1689, 2018. DOI: 10.1007/s00296-018-4095-0. 

*	Hashimoto M, Furu M, Yamamoto W, Fujimura T, Hara R, Katayama M, Ohnishi A, Akashi K, Yoshida S, Nagai K, Son Y, Amuro H, Hirano T, Ebina K, **Uozumi R**, Ito H, Tanaka M, Ohmura K, Fujii T, Mimori T. Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: The ANSWER cohort study. Arthritis Research & Therapy. 20(1), 165, 2018. DOI: 10.1186/s13075-018-1673-1. 

2017
*	**Uozumi R**, Hamada C. Interim decision-making strategies in adaptive designs for population selection using time-to-event endpoints. Journal of Biopharmaceutical Statistics. 27(1), 84-100, 2017. DOI: 10.1080/10543406.2016.1148714. -[Article PDF](https://www.tandfonline.com/doi/abs/10.1080/10543406.2016.1148714?journalCode=lbps20)-.

* **Uozumi R**, Hamada C. Adaptive seamless design for establishing pharmacokinetic and efficacy equivalence in developing biosimilars. Therapeutic Innovation & Regulatory Science. 51(6), 761-769, 2017. DOI: 10.1177/2168479017706526. 

*	Yamashita Y, **Uozumi R**, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Morita S, Akao M. Current status and outcomes of direct oral anticoagulant use in real-world atrial fibrillation patients: Fushimi AF Registry. Circulation Journal. 81(9), 1278-1285, 2017. DOI: 10.1253/circj.CJ-16-1337. 

*	Ishiguro T, Kagiyama N, **Uozumi R**, Odashima K, Takaku Y, Kurashima K, Morita S, Takayanagi N. Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality. Yale Journal of Biology and Medicine. 90(2), 165-181, 2017. 

*	Goto S, Hasegawa S, Hida K, **Uozumi R**, Kanemitsu Y, Watanabe T, Sugihara K, Sakai Y. Multicenter analysis of impact of anastomotic leakage on long-term oncological outcomes after curative resection of colon cancer. Surgery. 162(2), 317-324, 2017. DOI: 10.1016/j.surg.2017.03.005.

*	Hoshino N, Kawada K, Hida K, Goto S, **Uozumi R**, Hasegawa S, Sugihara K, Sakai Y. Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer. Medical Oncology. 34(8):138, 2017. DOI: 10.1007/s12032-017-0996-0. 

*	Tateya I, Koh YW, Tsang RK, Hong SS, **Uozumi R**, Kishimoto Y, Sugimoto T, Holsinger FC. Flexible next-generation robotic surgical system for transoral endoscopic hypopharyngectomy: a comparative preclinical study. Head & Neck. 40(1), 16-23, 2018. DOI: 10.1002/hed.24868. 

*	Nagami S, Oku Y, Yagi N, Sato S, **Uozumi R**, Morita S, Yamagata Y, Kayashita J, Tanimura K, Sato A, Takahashi R, Muro S. Breathing-swallowing discoordination is associated with frequent exacerbations of COPD. BMJ Open Respiratory Research. 4, e000202, 2017. DOI: 10.1136/bmjresp-2017-000202.

2016
*	Ishiguro T, Takayanagi N, **Uozumi R**, Baba Y, Kawate E, Kobayashi Y, Takaku Y, Kagiyama N, Shimizu Y, Morita S, Sugita Y. Diagnostic Criteria That Can Most Accurately Differentiate Allergic Bronchopulmonary Mycosis from Other Eosinophilic Lung Diseases: A Retrospective, Single-Center Study. Respiratory Investigation. 54(4), 264-271, 2016. DOI: 10.1016/j.resinv.2016.01.004. 

*	Ishiguro T, Kagiyama N, **Uozumi R**, Odashima K, Kurashima K, Morita S, Takayanagi N. Risk Factors for the Severity and Mortality of Pneumococcal Pneumonia: Importance of Usual Patients’ Performance Status. Journal of Infection and Chemotherapy. 22(10), 685-691, 2016. DOI: 10.1016/j.jiac.2016.07.008. 

*	Ishiguro T, Takayanagi N, **Uozumi R**, Tada M, Kagiyama N, Takaku Y, Shimizu Y, Sugita Y, Morita S. The Long-term Clinical Course of Chronic Eosinophilic Pneumoni. Internal Medicine. 55(17), 2373-2377, 2016. DOI: 10.2169/internalmedicine.55.6765.

*	Ishiguro T, Takayanagi N, Kanauchi T, **Uozumi R**, Kawate E, Takaku Y, Kagiyama N, Shimizu Y, Hoshi T, Morita S, Sugita Y. Clinical and Radiographic Comparison of Influenza Virus-associated Pneumonia among Three Viral Subtypes. Internal Medicine. 55(7), 731-737, 2016. DOI: 10.2169/internalmedicine.55.5227.  

*	Okita Y, Minakata K, Yasuno S, **Uozumi R**, Sato T, Ueshima K, Konishi H, Morita N, Harada M, Kobayashi J, Suehiro S, Kawahito K, Okabayashi H, Takanashi S, Ueda Y, Usui A, Imoto K, Tanaka H, Okamura Y, Sakata R, Yaku H, Tanemoto K, Imoto Y, Hashimoto K, Bando K. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multi-center study. European Journal of Cardio-Thoracic Surgery. 50(2), 374-382, 2016. DOI: 10.1093/ejcts/ezw035. 

2015
*	Hamatani Y, Ogawa H, **Uozumi R**, Iguchi M, Yamashita Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Morita S, Akao M. Low body weight is associated with the incidence of stroke in atrial fibrillation patients: Insight from the Fushimi AF Registry. Circulation Journal. 79(5), 1009-1017, 2015. DOI: 10.1253/circj.CJ-14-1245. 
